Similarly, TP53 loss (deletion 17) in chronic lymphocytic leukemia is among the worst prognostic findings [17], yet high-grade serous ovarian cancer, the vast majority of which carry P53 missense mutations [18], remain highly sensitive to platinum-based chemotherapy. The gene discussed is TP53; the disease is ovarian serous adenocarcinoma.